Cipla informs about acquisition

06 Jan 2024 Evaluate
Cipla has informed that Cipla (EU), wholly owned subsidiary of the Company in UK, has entered into a joint venture agreement with Kemwell Biopharma UK and MNI Ventures, Mauritius on 5th January, 2024 for incorporation of a joint venture company in USA.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1423.40 -1.35 (-0.09%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.